Re-evaluating the therapeutic misconception: response to Miller and Joffe

Area of Science:

• Bioethics
• Clinical Research Ethics
• Informed Consent

Background:

• The concept of therapeutic misconception (TM) is reviewed in response to Miller and Joffe.
• Concerns about TM focus on its impact on informed consent, not necessarily poorer participant outcomes.
• TM impairs participants' ability to provide adequate informed consent, infringing on dignitary interests and decision-making autonomy.

Discussion:

• The authors argue that Miller and Joffe's position largely aligns with their own, despite claims to the contrary.
• The debate centers on whether the prospect of poorer outcomes should be the primary motivator for dispelling TM.
• The paper critiques the premature acceptance of widespread tolerance for TM in clinical research.

Key Insights:

• Therapeutic misconception compromises the ethical foundation of informed consent in research.
• Protecting participants' dignitary interests and decision-making capacity is paramount.
• Empirical data on dispelling TM and its effects on recruitment are currently lacking.

Outlook:

• Further empirical research is needed to understand effective strategies for dispelling TM.
• The impact of interventions to address TM on participant recruitment requires investigation.
• A cautious approach is warranted regarding the tolerance of TM in clinical research settings.